Product How it works Pricing Blog FAQ About Contact
Tenax Therapeutics

Tenax Therapeutics (NASDAQ: TENX) net income

Tenax Therapeutics reported a net loss of $52.6m for fiscal 2025; in fiscal 2024 it reported a net loss of $17.6m. Earnings per share were −$1.34.

Tenax Therapeutics's best year of the last 10 was fiscal 2022. It reported a loss in 9 of those 10 years.

Net income, in millions of US dollars-43.92016-8.82017-14.12018-8.42019-9.92020-32.5202111.02022-7.72023-17.62024-52.62025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Net income by fiscal year

Fiscal yearNet incomeChangeNet marginEarnings per share
2025−$52.6m——−$1.34
2024−$17.6m——−$1.15
2023−$7.7m−169.8%—−$31.04
2022$11.0m———
2021−$32.5m———
2020−$9.9m———
2019−$8.4m———
2018−$14.1m———
2017−$8.8m———
2016−$43.9m———

The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Tenax Therapeutics net income compared with its sector

By net income for its latest fiscal year, Tenax Therapeutics ranks 261st of the 501 US health care companies with a page on Celsmar.

RankCompanyNet incomeNet margin
259thEvolus−$51.6m−17.4%
260thInvivyd−$52.5m−98.2%
261stTenax Therapeutics−$52.6m—
262ndOrchestra BioMed−$52.7m−157.4%
263rdCVRX−$53.3m−94.1%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the net income of Tenax Therapeutics

How much did Tenax Therapeutics earn in fiscal 2025?
Tenax Therapeutics reported a net loss of $52.6m for fiscal 2025. In fiscal 2024 it reported a net loss of $17.6m.
What are the earnings per share of Tenax Therapeutics?
They were −$1.34 in fiscal 2025, compared with −$1.15 in fiscal 2024.
What was the most profitable year for Tenax Therapeutics?
Of its last 10 fiscal years, fiscal 2022, with $11.0m.
Where does Tenax Therapeutics rank in its sector by net income?
It ranks 261st of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
Where do the figures for Tenax Therapeutics come from?
From the annual report (Form 10-K) that Tenax Therapeutics files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Tenax Therapeutics files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Tenax Therapeutics: the Tenax Therapeutics page · annual accounts · revenue · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.